Different patterns of second‐line treatment in type 2 diabetes after metformin monotherapy in Denmark, Finland, Norway and Sweden (D360 Nordic): A multinational observational study

AIMS: The understanding of second‐line use of glucose‐lowering drugs (GLDs) in the general population with type 2 diabetes (T2D) treatment is important as recent results have shown cardiovascular benefits with sodium‐glucose cotransporter‐2 inhibitors (SGLT‐2i) and glucagon‐like peptide‐1 receptor a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Endocrinol Diabetes Metab
Main Authors: Persson, Frederik, Bodegard, Johan, Lahtela, Jorma T., Nyström, Thomas, Jørgensen, Marit E., Jensen, Majken Linneman, Gulseth, Hanne L., Thuresson, Marcus, Hoti, Fabian, Nathanson, David, Norhammar, Anna, Birkeland, Kåre I., Eriksson, Johan G., Eriksson, Jan W.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6354817/
https://ncbi.nlm.nih.gov/pubmed/30815564
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/edm2.36
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados